Floor C. Loonstra

Amsterdam Neuroscience — Netherlands

Medicine · Health Sciences

9h-index255citations15works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Sclerosis Research Studies(12), Long-Term Effects of COVID-19(3), Polyomavirus and related diseases(3), Liver Disease Diagnosis and Treatment(2), Chronic Myeloid Leukemia Treatments(2)

Publications15 total

Association of Polygenic Risk Score With Lifetime Risk of Developing Multiple Sclerosis in a Population-Based Birth-Year Cohort
Neurology·2024· 4 citedOpen Access
The role of diet in multiple sclerosis onset and course: results from a nationwide retrospective birth‐year cohort
Annals of Clinical and Translational Neurology·2023· 9 citedOpen Access
The association between weight during early life and multiple sclerosis onset in a nationwide Dutch birth year cohort
Nutritional Neuroscience·2023· 1 cited
Association of Arachidonic Acid–Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple Sclerosis
Neurology·2023· 22 citedOpen Access
Association of volumetric MRI measures and disability in MS patients of the same age: Descriptions from a birth year cohort
Multiple Sclerosis and Related Disorders·2023· 10 citedOpen Access
Adipokines in multiple sclerosis patients are related to clinical and radiological measures
Journal of Neurology·2022· 15 citedOpen Access
Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple Sclerosis
Neurology Neuroimmunology & Neuroinflammation·2022· 15 citedOpen Access
The prevalence of internuclear ophthalmoparesis in a population-based cohort of individuals with multiple sclerosis
Multiple Sclerosis and Related Disorders·2022· 12 citedOpen Access
Project Y: The search for clues explaining phenotype variability in MS
Multiple Sclerosis and Related Disorders·2021· 17 citedOpen Access
Real-world keystroke dynamics are a potentially valid biomarker for clinical disability in multiple sclerosis
Multiple Sclerosis Journal·2020· 53 citedOpen Access
Response to letter ‘Lymphocyte counts and the risk of COVID-19 in people with MS’
Multiple Sclerosis Journal·2020Open Access
COVID-19 in multiple sclerosis: The Dutch experience
Multiple Sclerosis Journal·2020· 78 citedOpen Access
Serum neurofilaments as candidate biomarkers of natalizumab-associated PML
Pure Amsterdam UMC·2019
Infusion-related events during natalizumab: No need for post-infusion monitoring
Multiple Sclerosis Journal·2019· 4 citedOpen Access
Serum neurofilaments as candidate biomarkers of natalizumab associated progressive multifocal leukoencephalopathy
Annals of Neurology·2019· 15 citedOpen Access

Frequent Co-authors

Bernard M.J. Uitdehaag(13), Joep Killestein(10), Eva Strijbis(9), Lodewijk R. J. de Ruiter(8), Zoé L. E. van Kempen(5), Bastiaan Moraal(5), Menno M. Schoonheim(5), Charlotte E. Teunissen(4), Elske Hoitsma(2), Jop Mostert(2), Ka‐Hoo Lam(2), Frederik Barkhof(2), Helga E. de Vries(2), Inge M.W. Verberk(2), Martijn T. Wijburg(2), Mike P. Wattjes(2), Bob W. van Oosten(2), Brigit A. de Jong(2), KA Meijer(1), EME Coerver(1)